Zentek gets 180-day Nasdaq bid-price extension
Zentek Ltd. received a further 180‑day extension from Nasdaq to regain compliance with the exchange’s minimum $1.00 bid price requirement for continued listing.
Rhea-AI Filing Summary
Zentek Ltd. received a further 180‑day extension from Nasdaq to regain compliance with the exchange’s minimum $1.00 bid price requirement for continued listing. The new deadline to meet Nasdaq Listing Rule 5550(a)(2) is August 24, 2026.
The company’s shares will continue to trade on Nasdaq under the symbol “ZTEK” with no immediate impact on listing or trading status. To regain compliance, Zentek must maintain a closing bid price of at least $1.00 per share for a minimum of 10 consecutive business days on or before the new deadline.
Management plans to monitor the share price and consider available options to satisfy the requirement while continuing to advance its graphene-enabled advanced material technologies across healthcare, clean air and industrial applications.
Positive
- None.
Negative
- Nasdaq compliance risk remains: Zentek has only a 180‑day extension, until August 24, 2026, to achieve a closing bid of at least $1.00 for 10 consecutive business days, or its Nasdaq listing could be at risk under the exchange’s rules.
Insights
Nasdaq extension delays, but does not remove, Zentek’s listing risk.
Zentek has secured an additional 180 days, until August 24, 2026, to restore compliance with Nasdaq’s $1.00 minimum bid price rule. This keeps the shares trading under the symbol ZTEK without immediate listing consequences.
The key condition is maintaining a closing bid of at least $1.00 for 10 consecutive business days within the extension window. If this is not achieved, Nasdaq listing status could be at risk under the applicable rules, which would be a meaningful event for investors who value U.S. exchange liquidity.
Management indicates it will monitor the share price and consider available options, but the specific measures are not detailed here. The practical impact will hinge on whether Zentek can meet the 10‑day price test before August 24, 2026 under prevailing market conditions.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Zentek Ltd. (ZTEK) announce regarding its Nasdaq listing?
What is the new deadline for Zentek (ZTEK) to meet Nasdaq’s $1.00 bid requirement?
What conditions must Zentek Ltd. (ZTEK) satisfy to regain Nasdaq compliance?
How does Zentek’s management plan to address the Nasdaq bid price issue?
What business does Zentek Ltd. (ZTEK) focus on?
AI-generated analysis. How Rhea-AI works. Not financial advice.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
OF THE SECURITIES EXCHANGE ACT OF 1934
For the month of February 2026
Commission File Number: 001-41310
ZENTEK LTD.
(Registrant)
24 Corporate Court
Guelph, Ontario N1G 5G5 Canada
(Address of Principal Executive Offices)
Indicate by check mark whether the Registrant files or will file annual reports under cover of Form 20-F or Form 40-F.
Form 20-F ☐ Form 40-F ☒
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1): ☐
Indicate by check mark if the Registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7): ☐
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| ZENTEK LTD. | ||
| (Registrant) | ||
| Date: February 25, 2026 | By | /s/ Wendy Ford |
| Wendy Ford | ||
| Chief Financial Officer | ||
EXHIBIT INDEX
| Exhibit | Description of Exhibit | |
| 99.1 | Press Release dated February 25, 2026 - Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement | |
Zentek Ltd. Granted 180-Day Extension to Regain Compliance with Nasdaq's Minimum Bid Price Requirement
Guelph, Ontario, February 25, 2026 - Zentek Ltd. ("Zentek" or the "Company") (TSX-V: ZEN) (NASDAQ: ZTEK) announces that, further to its press release dated August 27, 2025, it has been granted a 180 calendar day extension from The Nasdaq Stock Market LLC ("Nasdaq") to regain compliance with the Nasdaq's minimum $1.00 bid price requirement set forth in Nasdaq Listing Rule 5550(a)(2) (the "Rule") for continued listing on Nasdaq (the "Minimum Bid Price Requirement"), following the expiration of the initial 180 calendar day period to regain compliance on February 23, 2026. The Company now has until August 24, 2026, to meet the Minimum Bid Price Requirement set forth in Nasdaq Listing Rule 5550(a)(2).
There is no immediate effect on the listing or trading of the Company's shares, which will continue to trade on the Nasdaq under the symbol "ZTEK." To regain compliance with the Rule, the Company must maintain a closing bid price of at least $1.00 per share for a minimum of ten (10) consecutive business days on or prior to August 24, 2026. Zentek's management intends to actively monitor the bid price for its Shares and will consider all available options to regain compliance with the Nasdaq minimum bid price requirement.
About Zentek Ltd.
Zentek Ltd. is a Canadian company advancing a portfolio of graphene-enabled advanced material technologies across healthcare, clean air and next-generation industrial applications. Zentek develops and scales materials-innovation solutions that aim to make partner products better, safer and more energy-efficient, while unlocking new high-value markets for ultra-high-purity graphite in nuclear, battery and semiconductor applications.
For further information:
Mohammed (Moe) Jiwan
Chief Executive Officer
Phone: 647-287-9582
Email: mjiwan2@zentek.com
To find out more about Zentek, please visit our website at www.Zentek.com. A copy of this news release and all material documents in respect of the Company may be obtained on Zentek's SEDAR+ profile at http://www.sedarplus.ca/.
Forward-Looking Statements
This news release contains forward-looking statements. Since forward-looking statements address future events and conditions, by their very nature they involve inherent risks and uncertainties. Although Zentek believes that the assumptions and factors used in preparing the forward-looking information in this news release are reasonable, undue reliance should not be placed on such information, which only applies as of the date of this news release, and no assurance can be given that such events will occur in the disclosed time frames or at all. Zentek refuses any intention or obligation to update or revise any forward-looking information, whether as a result of new information, future events or otherwise, other than as required by law.
Neither the TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in the policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.